What is the pediatric dose of Ceftriaxone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing of Ceftriaxone

The recommended pediatric dose of ceftriaxone is 50-100 mg/kg/day given once daily or divided every 12-24 hours, with a maximum daily dose of 4 grams. 1, 2, 3

Age-Specific Dosing Recommendations

Neonates

  • For neonates with postnatal age ≤7 days: 50 mg/kg/day given every 24 hours 1
  • For neonates with postnatal age >7 days and ≤2000 g: 50 mg/kg/day given every 24 hours 1
  • For neonates with postnatal age >7 days and >2000 g: 50-75 mg/kg/day given every 24 hours 1
  • Should not be used in hyperbilirubinemic neonates 1

Infants and Children

  • For bacterial meningitis: 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 1
  • For severe infections including pneumonia: 50-100 mg/kg/day given once daily or divided every 12-24 hours 1
  • For less severe infections: 50-75 mg/kg/day given once daily or divided every 12-24 hours 1

Indication-Specific Dosing

Meningitis

  • For bacterial meningitis: 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 1, 4, 5
  • Recent evidence suggests that once-daily dosing (100 mg/kg) may achieve earlier target attainment in CSF compared to twice-daily dosing 5

Pneumonia

  • For community-acquired pneumonia: 50-100 mg/kg/day given once daily or divided every 12-24 hours 1
  • For pneumococcal pneumonia with penicillin resistance (MICs ≥4.0 μg/mL): 100 mg/kg/day given every 12-24 hours 1

Intra-abdominal Infections

  • For complicated intra-abdominal infections: 50-75 mg/kg/day given every 12-24 hours 1

Other Serious Infections

  • For sepsis: 50-75 mg/kg/day given every 12-24 hours 1, 6
  • For osteomyelitis/septic arthritis: 50-100 mg/kg/day given once daily 6

Administration Considerations

  • Intravenous doses should be infused over 30 minutes 2, 3
  • Intramuscular administration is completely absorbed with peak concentrations occurring between 2-3 hours post-dose 2, 3
  • Once-daily administration (50-80 mg/kg) has been shown to be effective for many serious bacterial infections in children, with a clinical cure rate of 94% 6

Pharmacokinetic Considerations

  • In pediatric patients with meningitis, ceftriaxone penetrates inflamed meninges with CSF concentrations of 5.6-6.4 μg/mL after IV doses of 50-75 mg/kg 2, 3, 4
  • The elimination half-life in pediatric patients ranges from 4.3-4.6 hours 2, 3
  • For patients with augmented renal clearance (eGFR >80 mL/min/1.73m²), twice-daily dosing of 50 mg/kg may improve target attainment 7

Important Precautions

  • Ceftriaxone should not be administered simultaneously with calcium-containing IV solutions, including continuous calcium-containing infusions 2, 3
  • Dosage adjustment is generally not required in patients with renal or hepatic impairment for doses up to 2 g per day 2, 3
  • For critically ill children, the standard 100 mg/kg once-daily dose provides adequate exposure for most susceptible pathogens 7

Monitoring

  • Clinical response should be monitored within 24-48 hours of initiating therapy 8
  • For prolonged therapy, periodic monitoring of complete blood count, liver and renal function tests is recommended 2, 3

By following these dosing recommendations, ceftriaxone can be effectively and safely used in pediatric patients for a variety of serious bacterial infections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.